PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Study shows timely transition from pediatric to adult care is critical for young adults with sickle cell disease

Waiting more than six months raises likelihood of hospital stay in first two years of adult care

2024-07-15
(Press-News.org) Sickle cell disease is the most common inherited red blood cell disorder in the United States and can lead to health problems including organ dysfunction, acute chest syndrome and strokes over a patient’s lifespan. According to a new study, individuals living with sickle cell disease who experience a delay of more than six months after transferring from pediatric to adult care are twice as likely to be hospitalized compared to those who transition in less than two months.

In the study, Kristen Howell, PhD, assistant professor in the Department of Epidemiology and Biostatistics at the Texas A&M University School of Public Health, and colleagues used data on individuals with sickle cell disease who completed pediatric care at St. Jude Children’s Research Hospital in Memphis between 2012 and 2018. The clinic at St. Jude runs a transition preparation program that starts at age 12 in educating patients on the transition process and introduces them to adult health care facilities at the age of 17. Current guidelines state that individuals with chronic disease should transfer from pediatric care to adult care within six months; however, this had not been studied in a sickle cell population.

Howell and colleagues followed patients from their first adult care visit through the end of 2020 and excluded patients who did not have an adult care appointment after leaving pediatric care. The researchers measured the length of time between the last pediatric visit and first adult appointment and categorized that length as less than two months, two to six months and six months or greater. They also tracked routine outpatient visits, inpatient hospitalizations and emergency department use during the study period. Lastly, the analysis included data on factors like sickle cell disease genotype, patient sex and health insurance type at time of transfer.

The analysis found that around 88 percent of the study participants successfully transferred to adult care within the recommended six-month period, with a median transfer gap of about a month and a half. Howell noted that those who transitioned to adult care within the recommended period had more outpatient visits and less acute care use. In contrast, those who had transfer gaps longer than six months were two times more likely to need hospitalization.

“There are several barriers to transition including challenges in care coordination, insurance coverage, and institutional and practioner bias. Transition programs are designed to help address these barriers,” Howell said. “The goal of this study is to provide evidence to support the transition guidelines of a six-month transfer gap and improve the health of individuals with sickle cell disease as they enter adulthood.”

The researchers suggest that transition programs that include early introductions to adult care, promotion of patient self-efficacy and health literacy education help improve health outcomes.This confirms that a swift transfer — specifically, less than six months — from pediatric to adult care may reduce the use of acute care services in adult care.

END


ELSE PRESS RELEASES FROM THIS DATE:

University of Cincinnati study: Long-term stroke survival improving, but racial disparities remain

University of Cincinnati study: Long-term stroke survival improving, but racial disparities remain
2024-07-15
Overall rates of long-term survival following stroke are improving, but Black individuals experience worse long-term outcomes compared to white individuals, according to University of Cincinnati research published online July 15 in Neurology®, the medical journal of the American Academy of Neurology. UC’s David Robinson, MD, corresponding author on the research, said prior studies had examined short-term stroke outcomes of 30 or 60 days, but this time the team looked at survival rates five years past a person’s stroke. “This was ...

National Institutes of Health grant could mean progress toward improved outcomes for stroke patients

National Institutes of Health grant could mean progress toward improved outcomes for stroke patients
2024-07-15
The Associate Dean of Research at the University of Tennessee Health Science Center’s College of Nursing has received a two-year, $421,188 grant from the National Institutes of Health (NIH) to improve cognitive screening in people who suffer from a devastating type of stroke called aneurysmal subarachnoid hemorrhage (aSAH). Professor Ansley Stanfill, PhD, RN, FAAN, has devoted her program of research to improving outcomes for people who survive strokes. Her latest grant aims to determine if an existing screening tool can be used in a new way to assess patients following aSAH and trigger a ...

SfN establishes James L. Roberts Endowed Fund

2024-07-15
Washington, D.C. – The Society for Neuroscience (SfN) has received $128,000 from the estate of James L. Roberts, PhD. With the funds, SfN Council voted to create a new long-term endowed fund, The James L. Roberts Fund, and will use the income from its investments to create and perpetually fund James L. Roberts Trainee Professional Development Awards (TPDAs) beginning at Neuroscience 2024.   “I knew Jimmy Roberts very well. We basically launched neurobiology at Sinai when we co-directed the Fishberg Research Center for Neurobiology at Mount Sinai from 1989–2002,” said incoming SfN President John Morrison. “Jimmy was an outstanding ...

Unlocking the mystery of preexisting drug resistance: New study sheds light on cancer evolution

Unlocking the mystery of preexisting drug resistance: New study sheds light on cancer evolution
2024-07-15
CLEVELAND—The evolution of resistance to diseases, from infectious illnesses to cancers, poses a formidable challenge. Despite the expectation that resistance-conferring mutations would dwindle in the absence of treatment due to a reduced growth rate, preexisting resistance is pervasive across diseases that evolve—like cancer and pathogens—defying conventional wisdom. In cancer, it is well known that small numbers of drug-resistant cells likely exist in tumors even before they’re treated. In something of a paradox, before treatment, these mutants have been repeatedly shown to have lower fitness than the surrounding ancestor cells from which they arose. It leads ...

New study reveals critical role of C1q protein in neuronal function and aging

New study reveals critical role of C1q protein in neuronal function and aging
2024-07-15
BOSTON, Mass. (July 15, 2024)—A groundbreaking study conducted at the lab of Beth Stevens, PhD, at Boston Children’s Hospital has revealed that an immune protein impacts neuronal protein synthesis in the aging brain. Previous work from the Stevens lab had uncovered that immune cells in the central nervous system, microglia, help prune synapses in the developing brain by tagging synapses with the immune protein C1q. New research led by Nicole Scott-Hewitt, published in Cell, shows that neurons can also internalize C1q. C1q seems to influence protein production inside neurons by interacting with ribosomal proteins, RNA-binding proteins, and ...

New research demonstrates potential for increasing effectiveness of popular diabetes, weight-loss drugs

2024-07-15
A network of proteins found in the central nervous system could be harnessed to increase the effectiveness and reduce the side effects of popular diabetes and weight-loss drugs, according to new research from the University of Michigan.    The study, appearing today in the Journal of Clinical Investigation, focused on two proteins called melanocortin 3 and melanocortin 4 found primarily on the surface of neurons in the brain that play a central role in regulating feeding behavior and maintaining the body's energy balance.   Melanocortin ...

Understanding the 3D ice-printing process to create micro-scale structures

Understanding the 3D ice-printing process to create micro-scale structures
2024-07-15
Advances in 3D printing have enabled many applications across a variety of disciplines, including medicine, manufacturing, and energy. A range of different materials can be used to print both simple foundations and fine details, allowing for the creation of structures with tailored geometries. However, creating structures with micro-scale, precise internal voids and channels still poses challenges. Scaffolds used in tissue engineering, for example, must contain a three-dimensional complex network of conduits that mimic the human vasculature. With traditional additive manufacturing, where the material is deposited layer ...

Children’s Hospital of Philadelphia researchers develop antioxidant strategy to address mitochondrial dysfunction caused by SARS-CoV-2 virus

2024-07-15
Philadelphia, July 15, 2024 – Building upon groundbreaking research demonstrating how the SARS-CoV-2 virus disrupts mitochondrial function in multiple organs, researchers from Children’s Hospital of Philadelphia (CHOP) demonstrated that mitochondrially-targeted antioxidants could reduce the effects of the virus while avoiding viral gene mutation resistance, a strategy that may be useful for treating other viruses. The preclinical findings were recently published in the journal Proceedings ...

How climate change is altering the Earth’s rotation

2024-07-15
Climate change is causing the ice masses in Greenland and Antarctica to melt. Water from the polar regions is flowing into the world’s oceans –and especially into the equatorial region. “This means that a shift in mass is taking place, and this is affecting the Earth’s rotation,” explains Benedikt Soja, Professor of Space Geodesy at the Department of Civil, Environmental and Geomatic Engineering at ETH Zurich. “It’s like when a figure skater does a pirouette, first holding her arms close to her body and then stretching ...

Comparison of FDG-PET/CT and CT for treatment evaluation of patients with unresectable malignant pleural mesothelioma

Comparison of FDG-PET/CT and CT for treatment evaluation of patients with unresectable malignant pleural mesothelioma
2024-07-15
“FDG-PET is generally considered as a useful metabolic evaluation tool, while it is also thought to have an emerging role for assessment of systemic therapy response.” BUFFALO, NY- July 15, 2024 – A new research paper was published in Oncotarget's Volume 15 on June 20, 2024, entitled, “Comparison of FDG-PET/CT and CT for evaluation of tumor response to nivolumab plus ipilimumab combination therapy and prognosis prediction in patients with unresectable malignant pleural mesothelioma.” Malignant pleural mesothelioma (MPM) is an aggressive neoplasm and affected ...

LAST 30 PRESS RELEASES:

Rugged Falklands landscape was once a lush rainforest

Dizziness in older adults is linked to higher risk of future falls

Triptans more effective than newer, more expensive migraine drugs

Iron given through the vein corrects iron deficiency anaemia in pregnant women faster and better than iron taken by mouth

The Lancet Neurology: Air pollution, high temperatures, and metabolic risk factors driving global increases in stroke, with latest figures estimating 12 million cases and over 7 million deaths from st

Incidence of neuroleptic malignant syndrome during antipsychotic treatment in children and youth

Levels of protection from different cycle helmets revealed by new ratings

Pupils with SEND continue to fall behind their peers

Half of heavier drinkers say calorie labels on alcohol would lead to a change in their drinking habits

Study first to link operating room design to shorter surgery

New study uncovers therapeutic inertia in the treatment of women with multiple sclerosis

Cancer Cooperative Group leaders propose a re-engineering of the nation’s correlative science program for cancer

Nawaz named ASME Fellow

U2opia signs license to commercialize anomaly-detection technology for cybersecurity

Explaining dramatic planetwide changes after world’s last ‘Snowball Earth’ event

Cleveland Clinic study is first to show success in treating rare blood disorder

Bone marrow cancer drug shows success in treatment of rare blood disorder

Clinical trial successfully repurposes cancer drug for hereditary bleeding disorder

UVA Engineering professor awarded $1.6M EPA grant to reduce PFAS accumulation in crops

UVA professor receives OpenAI grant to inform next-generation AI systems

New website helps researchers overcome peer reviewers’ preference for animal experiments

Can the MIND diet lower the risk of memory problems later in life?

Some diabetes drugs tied to lower risk of dementia, Parkinson’s disease

Propagated corals reveal increased resistance to bleaching across the Caribbean during the fatal heatwave of 2023

South African rock art possibly inspired by long-extinct species

Even marine animals in untouched habitats are at risk from human impacts

Hexagonal electrohydraulic modules shape-shift into versatile robots

Flexible circuits made with silk and graphene on the horizon

Scott Emr and Wesley Sundquist awarded 2024 Horwitz Prize for discovering the ESCRT pathway

Versatile knee exo for safer lifting

[Press-News.org] Study shows timely transition from pediatric to adult care is critical for young adults with sickle cell disease
Waiting more than six months raises likelihood of hospital stay in first two years of adult care